In clinical trials, a SAS programmer observes undigested change facts in statistical tables, lists, and numbers used by regulators to evaluate a drug or device. SAS programming for scientific experiments […]
Archive for Weltrix
SDTM vs ADaM: Understanding CDISC Requirements for Regulatory Submission
By Weltrix
- July 8, 2026
A sponsor submits a dataset package to the FDA, and three weeks later the review team sends back a technical rejection. Not because the drug data was wrong. Because the […]
Common Statistical Mistakes in Clinical Trials and How to Avoid Them
By Weltrix
- July 4, 2026
A clinical trial can fail for reasons that have nothing to do with the molecule, the device, or the protocol’s clinical logic – a sample size assumption from a small […]
AI-Enabled Clinical Data Management: Where the Opportunity Ends and the Risk Begins
By Weltrix
- July 4, 2026
The data problem nobody wants to admit out loud A phase 3 trial today generates roughly four times the data points it did in 2012 – from just under a […]
Why Biometrics CRO India Is Growing in Global Clinical Research
By Weltrix
- July 2, 2026
India’s clinical research sector has been building real momentum over the past decade. Not just in patient recruitment or cost advantages, but specifically in the technical and scientific backbone of […]
What Is Database Design and Build in Clinical Trials? A Complete Guide
By Weltrix
- July 1, 2026
Every clinical trial tells a story about a drug, a population, or an outcome, and that story is only as credible as the data behind it. Database design and build […]
What Are EDC Data Management Services and Why Do Clinical Trials Need Them?
By Weltrix
- July 1, 2026
Clinical trials generate enormous volumes of data — patient vitals, adverse events, lab results, concomitant medications, protocol deviations. Every data point matters. Every number that enters a database must be […]
Why Small Biotech Companies Choose Specialized Biometrics CROs
By Weltrix
- June 29, 2026
You’ve signed with a full-service CRO. Six months in, your statistical programming lead has changed twice, your data management timeline has slipped behind your clinical timeline, and nobody on the […]
6 Biometrics Trends Redefining Clinical Trial Strategy in 2026
By Weltrix
- June 24, 2026
Clinical biometrics has always sat at the center of drug development. What’s changed in 2026 is where it sits in the timeline. For decades, biometrics operated at the back end […]
10 Ways a Biometrics CRO Improves Clinical Trial Quality and Compliance
By Weltrix
- June 22, 2026
A Phase III dataset with a clean audit trail and a shaky one can look identical on the surface. The difference only shows up when an FDA reviewer or an […]
